189 related articles for article (PubMed ID: 22832710)
21. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
Garrido C; Roulet V; Chueca N; Poveda E; Aguilera A; Skrabal K; Zahonero N; Carlos S; García F; Faudon JL; Soriano V; de Mendoza C
J Clin Microbiol; 2008 Mar; 46(3):887-91. PubMed ID: 18199789
[TBL] [Abstract][Full Text] [Related]
23. Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection.
Rieder P; Joos B; Scherrer AU; Kuster H; Braun D; Grube C; Niederöst B; Leemann C; Gianella S; Metzner KJ; Böni J; Weber R; Günthard HF
Clin Infect Dis; 2011 Dec; 53(12):1271-9. PubMed ID: 21998286
[TBL] [Abstract][Full Text] [Related]
24. Current tests to evaluate HIV-1 coreceptor tropism.
Rose JD; Rhea AM; Weber J; Quiñones-Mateu ME
Curr Opin HIV AIDS; 2009 Mar; 4(2):136-42. PubMed ID: 19339953
[TBL] [Abstract][Full Text] [Related]
25. HIV-2 A-subtype gp125c₂-v₃-c₃ mutations and their association with CCR5 and CXCR4 tropism.
Dimonte S; Svicher V; Salpini R; Ceccherini-Silberstein F; Perno CF; Babakir-Mina M
Arch Virol; 2011 Nov; 156(11):1943-51. PubMed ID: 21814863
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.
Soulié C; Fourati S; Lambert-Niclot S; Malet I; Wirden M; Tubiana R; Valantin MA; Katlama C; Calvez V; Marcelin AG
J Antimicrob Chemother; 2010 Apr; 65(4):749-51. PubMed ID: 20150182
[TBL] [Abstract][Full Text] [Related]
27. Comment on: High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.
Raymond S; Delobel P; Izopet J
J Antimicrob Chemother; 2010 Sep; 65(9):2056-7; author reply 2058-9. PubMed ID: 20554569
[No Abstract] [Full Text] [Related]
28. HIV-1 coreceptor usage determination in clinical isolates using clonal and population-based genotypic and phenotypic assays.
Van Baelen K; Vandenbroucke I; Rondelez E; Van Eygen V; Vermeiren H; Stuyver LJ
J Virol Methods; 2007 Dec; 146(1-2):61-73. PubMed ID: 17640743
[TBL] [Abstract][Full Text] [Related]
29. No selection of CXCR4-using variants in cell reservoirs of dual-mixed HIV-infected patients on suppressive maraviroc therapy.
Raymond S; Nicot F; Carcenac R; Jeanne N; Cazabat M; Requena M; Cuzin L; Delobel P; Izopet J;
AIDS; 2016 Mar; 30(6):965-8. PubMed ID: 26752281
[TBL] [Abstract][Full Text] [Related]
30. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of genotypic tropism prediction tests compared with in vitro co-receptor usage in HIV-1 primary isolates of diverse subtypes.
Delgado E; Fernández-García A; Vega Y; Cuevas T; Pinilla M; García V; Sánchez M; González M; Sánchez AM; Thomson MM; Pérez-Álvarez L
J Antimicrob Chemother; 2012 Jan; 67(1):25-31. PubMed ID: 22010208
[TBL] [Abstract][Full Text] [Related]
32. High concordance between the position-specific scoring matrix and geno2pheno algorithms for genotypic interpretation of HIV-1 tropism: V3 length as the major cause of disagreement.
Seclén E; Soriano V; González MM; Gómez S; Thielen A; Poveda E
J Clin Microbiol; 2011 Sep; 49(9):3380-2. PubMed ID: 21734029
[TBL] [Abstract][Full Text] [Related]
33. High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.
Seclén E; Garrido C; González Mdel M; González-Lahoz J; de Mendoza C; Soriano V; Poveda E
J Antimicrob Chemother; 2010 Jul; 65(7):1486-92. PubMed ID: 20427374
[TBL] [Abstract][Full Text] [Related]
34. Concordance between HIV-1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA.
Verhofstede C; Brudney D; Reynaerts J; Vaira D; Fransen K; De Bel A; Seguin-Devaux C; De Wit S; Vandekerckhove L; Geretti AM
HIV Med; 2011 Oct; 12(9):544-52. PubMed ID: 21518222
[TBL] [Abstract][Full Text] [Related]
35. Accurate quantification of CXCR4-using HIV-1 variants by Illumina deep-sequencing.
Raymond S; Delaugerre C; Nicot F; Assoumou L; Lancar R; Beniguel L; Izopet J;
AIDS; 2018 Oct; 32(16):2429-2431. PubMed ID: 30102658
[TBL] [Abstract][Full Text] [Related]
36. Co-receptor switch during HAART is independent of virological success.
Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
[TBL] [Abstract][Full Text] [Related]
37. Improved V3 genotyping with duplicate PCR amplification for determining HIV-1 tropism.
Raymond S; Recordon-Pinson P; Saliou A; Delobel P; Nicot F; Descamps D; Marcelin AG; Flandre P; Calvez V; Masquelier B; Izopet J;
J Antimicrob Chemother; 2011 Sep; 66(9):1972-5. PubMed ID: 21676905
[TBL] [Abstract][Full Text] [Related]
38. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.
Raymond S; Delobel P; Mavigner M; Cazabat M; Souyris C; Sandres-Sauné K; Cuzin L; Marchou B; Massip P; Izopet J
AIDS; 2008 Sep; 22(14):F11-6. PubMed ID: 18753930
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic assays for the determination of coreceptor tropism in HIV-1 infected individuals.
Braun P; Wiesmann F
Eur J Med Res; 2007 Oct; 12(9):463-72. PubMed ID: 17933728
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of GS Junior and MiSeq next-generation sequencing technologies as an alternative to Trugene population sequencing in the clinical HIV laboratory.
Ram D; Leshkowitz D; Gonzalez D; Forer R; Levy I; Chowers M; Lorber M; Hindiyeh M; Mendelson E; Mor O
J Virol Methods; 2015 Feb; 212():12-6. PubMed ID: 25445792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
